RecruitingNCT01000883

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior


Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

10,000 participants

Start Date

Dec 1, 1998

Study Type

OBSERVATIONAL

Conditions

Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from women with locally advanced or metastatic breast cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is taking biopsy (small tissue) samples from breast cancer tumors at different points during treatment to study how cancer cells change over time in response to therapy. **You may be eligible if...** - You are 18 or older with suspected or known breast cancer (early or metastatic/spreading) - Your tumor can be safely biopsied as determined by your doctor - You are in reasonably good health (ECOG performance status 0–2) - You have adequate blood counts if a biopsy of a vital organ (lung, liver) is needed **You may NOT be eligible if...** - You have a serious medical or psychiatric condition that makes participation unsafe or inappropriate - You have dementia or a condition that prevents you from giving informed consent - You have a serious allergy to local anesthetics (such as lidocaine) - You are pregnant - You have a heart condition that makes biopsy unsafe - You have received bevacizumab or similar anti-angiogenesis drugs less than 6 weeks ago (for vital organ biopsies) or less than 2 weeks ago (for breast/skin biopsies) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERbiologic sample preservation procedure

approximately 16-20 milligrams of tumor tissue per core will be obtained for research purposes.

OTHERlaboratory biomarker analysis

Evaluation of biomarkers will occur as questions are asked in subsequent correlative studies.

PROCEDUREbiopsy

cancer tissue will be taken from the primary breast cancer site as well as the metastatic tumor sites. Two tubes of whole blood will also be collected.


Locations(1)

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01000883


Related Trials